Eagle's Eye View: Your Weekly CV Update From ACC.org (Week of December 16)
This week's View summarizes an article on the safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome who are treated with percutaneous coronary intervention, an article on the patient and health system-level factors associated with hospital readmission within 90 days after acute stroke or transient ischemic attack, and a trial that showed that an angiotensin receptor blocker was superior to placebo at slowing the rate of aortic root dilatation in patients with Marfan syndrome.
Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Arrhythmias and Clinical EP, Cardiac Surgery, Congenital Heart Disease and Pediatric Cardiology, Invasive Cardiovascular Angiography and Intervention, Prevention, Pulmonary Hypertension and Venous Thromboembolism, Anticoagulation Management and ACS, Anticoagulation Management and Atrial Fibrillation, Anticoagulation Management and Venothromboembolism, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and CHD and Pediatrics, Congenital Heart Disease, CHD and Pediatrics and Arrhythmias, CHD and Pediatrics and Interventions, CHD and Pediatrics and Prevention, CHD and Pediatrics and Quality Improvement, Interventions and ACS, Interventions and Structural Heart Disease, Interventions and Vascular Medicine
Keywords: EaglesEyeView, Acute Coronary Syndrome, Adrenergic beta-Antagonists, Angiotensin Receptor Antagonists, Anticoagulants, Aortic Diseases, Atrial Fibrillation, Blood Pressure, Blood Pressure Determination, Brain Ischemia, Cerebral Hemorrhage, Comorbidity, Dilatation, Fibrinolytic Agents, Heart Defects, Congenital, Hemorrhage, Intracranial Hemorrhages, Ischemic Attack, Transient, Losartan, Marfan Syndrome, Myocardial Infarction, Patient Discharge, Patient Readmission, Percutaneous Coronary Intervention, Primary Prevention, Rehabilitation, Secondary Prevention, Stents, Stroke, Thrombosis, Treatment Outcome, Vascular Diseases, Vitamin K, Warfarin, Vascular Diseases, Venous Thromboembolism, Arrhythmias, Cardiac, Cardiac Surgical Procedures
< Back to Listings